Abstract
Objective
To investigate the efficacy of a herbal formula in the prevention of influenza or influenza-like syndrome among elderies residing in old-people’s home in Hong Kong. The secondary objectives are to investigate the quality of life (QOL) and symptomology changes among the herbal users and to evaluate the safety of this formula.
Methods
In ten old people’s home or community centres in New Territories, Hong Kong, 740 eligible subjects agreed to join the study and were randomized to receive a herbal formula or a placebo on alternate days over 8 weeks. Among those 740 participants, 113 had provided blood samples for immunological assessments before and after the study drug. Assessments were done at 0, 4, 8 and 12 weeks. Participants were instructed to keep a daily record of body temperature and any symptoms as sore throat, myalgia, running nose or cough, and to report to assessor accordingly. Those reporting body temperature of 37.8 °C and above would be visited and a proper nasopharyngeal swab be taken for viral study.
Results
Seventy-two participants developed influenza-like-symptoms but none of them was proven influenza in their nasopharyngeal swabs, 40 of these patients belonged to the herbal group and 32 to the placebo group, without significant differences between groups. The difference on the changes in QOL between the two groups was not statistically significant. However, in the immunological study, the natural killer cell absolute count was significantly increased in the herbal group compared with the placebo group (463±253 vs 413±198, P<0.05).
Conclusions
The herbal preparation was not effective compared with placebo in the prevention of influenza-like syndrome. It was however safe and possibly supporting immunological responses.
Keywords: complementary medicine, influenza, herbal treatment
Footnotes
Supported by the Grant from Eu Yan Sang (Hong Kong) Ltd.
References
- 1.Lin L., Han Y., Yang Z.M. Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese medicine and Western medicine. Chin J Integr Tradit West Med (Chin) 2003;23:409–413. [PubMed] [Google Scholar]
- 2.Tam J.S. Influenza A (H5N1) in Hong Kong: an overview. Vaccine. 2002;20Suppl2:S77–S81. doi: 10.1016/S0264-410X(02)00137-8. [DOI] [PubMed] [Google Scholar]
- 3.Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186. doi: 10.1001/jama.289.2.179. [DOI] [PubMed] [Google Scholar]
- 4.Lau J.T.F., Leung P.C., Wong E.L.Y., Fong C., Cheng K.F., Zhang S.C., et al. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. J Altern Complem Med. 2005;11:49–55. doi: 10.1089/acm.2005.11.49. [DOI] [PubMed] [Google Scholar]
- 5.Poon P.M.K., Wong C.K., Fung K.P., Fong C.Y., Wong E.L.Y., Lau J.T.F., et al. Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a selfcontrol study. Am J Chin Med. 2006;34:13–21. doi: 10.1142/S0192415X0600359X. [DOI] [PubMed] [Google Scholar]
- 6.Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 health survey—manual and interpretation guide. Boston, MA: The Health Institute; 1993. [Google Scholar]
- 7.Lam C.L.K., Gandek B., Ren X.S., Chan M.S. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol. 1998;51:1139–1147. doi: 10.1016/S0895-4356(98)00105-X. [DOI] [PubMed] [Google Scholar]
- 8.Centers for Disease Control and Prevention. Citing Websites. In seasonal influenza (flu)—key facts about seasonal flu vaccine. Retrieved Aug 15, 2011 Available at: http://www.cdc.gov/FLU/protect/keyfacts.htm.
- 9.Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectives of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–1836. doi: 10.1016/S0264-410X(02)00041-5. [DOI] [PubMed] [Google Scholar]
- 10.Schooling C.M., Wong L.C., Chau J., Cheung A., Ho A., McGhee S.M. Cost-effectiveness of influenza vaccination for elderly people living in the community. Hong Kong Med J. 2009;15:44–47. [PubMed] [Google Scholar]
- 11.Kmietowicz Z. Opposition to swine flu vaccine among health staff and the public seems to be growing worldwide. BMJ. 2009;339:476–477. doi: 10.1136/bmj.b3461. [DOI] [PubMed] [Google Scholar]
- 12.Henrich N., Holmes B. The public’s acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1. Emerg Health Threats J. 2009;2:e8. doi: 10.3134/ehtj.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chor J.S.Y., Ngai K.L.K., Goggins B.W., Wong M.C.S., Wong S.Y.S., Lee N., et al. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ. 2009;339:b3391. doi: 10.1136/bmj.b3391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lau J.T.F., Yeung N.C.Y., Choi K.C., Cheng M.Y.M., Tsui H.Y., Griffiths S. Acceptability of A/H1N1 vaccinatin during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ. 2009;399:b4164. doi: 10.1136/bmj.b4164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Benitez MA. $200m lost as H1N1 vaccine to be dumped. The Standard Newspaper. Retrieved 2010, June 10 Available at: http://www.thestandard.com.hk/.
- 16.Stobbe M. Millions of swine flu vaccine doses have expired and will be burned. CNSNews.com. Retrieved 2010 July 1 Available at: http://www.cnsnews.com/node/68848.